1. Home
  2. EBS
  3. Earnings

AI Earnings Predictions for Emergent Biosolutions Inc. (EBS)

Machine learning predictions based on historical earnings data and price patterns

Latest Prediction

SELL

1-Day Prediction

-8.77%

$5.85

15% positive prob.

5-Day Prediction

-13.92%

$5.52

15% positive prob.

20-Day Prediction

-16.41%

$5.36

14% positive prob.

Price at prediction: $6.42 Confidence: 70.5% Model AUC: 1.0000 Quarter: Q3 2026

Historical Earnings Predictions

Quarter Signal 1D Return 5D Return 20D Return Confidence Actual 5D
Q3 2026 SELL -8.77% -13.92% -16.41% 70.5% Pending
Q2 2026 SELL -8.70% -14.38% -19.66% 100.0% Pending
Q1 2026 BUY +25.20% +25.45% +26.13% 100.0% +10.94%
Q4 2025 SELL -7.06% -13.51% -18.97% 100.0% -23.96%

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q3

Q3 2026 Earnings

8-K SELL

Nov 2, 2026 · 70% conf.

AI Prediction SELL

1D

-8.77%

$5.85

Act: +6.21%

5D

-13.92%

$5.52

20D

-16.41%

$5.36

Price: $6.42 Prob +5D: 15% AUC: 1.000
0001367644-26-000110

EX-99.1

2 ebs202609-30ex99er.htm

EX-99.1 ER 11.2.26

Document

EMERGENT BIOSOLUTIONS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

•Third Quarter 2026 Total Revenues of $110.0 million

•Third Quarter 2026 Net Loss of $32.7 million and Net Loss Margin was (30)%

•Third Quarter 2026 Adjusted Net Loss of $18.7 million

•Third Quarter 2026 Gross Margin % of 14% and Adjusted Gross Margin % of 28%

•Third Quarter 2026 Adjusted EBITDA was a loss of $4.6 million and Adjusted EBITDA Margin was (4)%

GAITHERSBURG, Md., November 2, 2026—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2026.

“Emergent's third-quarter results, which include revenue of $110.0 million inline with our guidance, were primarily driven by our diverse biodefense/medical countermeasures and naloxone portfolio, underscoring the importance of disciplined execution as we advance our multi-year transformation,” said Joe Papa, president and chief executive officer of Emergent BioSolutions. “We remain focused on our turnaround priorities and strengthening our financial position, which includes improving operating performance, reducing debt, creating long-term shareholder value, continuously demonstrating high standards of quality and compliance in all we do and delivering on our mission to protect and save lives.”

FINANCIAL HIGHLIGHTS (1)

Q3 2026 vs. Q3 2025

($ in millions, except per share amounts)Q3 2026Q3 2025% Change

Total Revenues$110.0 $231.1 (52)%

Net Income (Loss)$(32.7)$51.2 (164)%

Net Income (Loss) per Diluted Share$(0.64)$0.91 (170)%

Adjusted Net Income (Loss) (2) $(18.7)$65.2 (129)%

Adjusted Net Income (Loss) per Diluted Share (2) $(0.36)$1.15 (131)%

Adjusted EBITDA (2) $(4.6)$92.6 (105)%

Net Income (Loss) Margin(30)%22 %

Adjusted EBITDA Margin (2) (4)%40 %

Gross Margin % 14 %54 %

Adjusted Gross Margin % (2) 28 %62 %

Year to Date ("YTD") 2026 vs YTD 2025

($ in millions, except per share amounts)YTD 2026YTD 2025% Change

Total Revenues$500.4 $594.2 (16)%

Net Income (Loss)$(206.1)$107.2 (292)%

Net Income (Loss) per Diluted Share$(3.99)$1.89 (311)%

Adjusted Net Income (2) $24.1 $120.5 (80)%

Adjusted Net Income per Diluted Share (2) $0.47 $2.13 (78)%

Adjusted EBITDA (2) $127.5 $204.8 (38)%

Net Income (Loss) Margin(41)%18 %

Adjusted EBITDA Margin (2) 25 %34 %

Gross Margin % 39 %48 %

Adjusted Gross Margin % (2) 49 %57 %

1

RECENT BUSINESS UPDATES

•Announced Rich Lindahl, Executive Vice President, Chief Financial Officer will retire from Emergent, effective December 31, 2026, and will stay on as a part-time advisor through March 31, 2027; Frank Vargo, Vice President, Treasurer, will serve as interim Chief Financial Officer beginning January 1, 2027

•Completed repurchase of $75 million aggregate principal amount of Senior Unsecured Notes

•Implemented restructuring efforts aimed to improve overall cost structure, drive efficiencies and align resourcing to the current needs of the organization, including creation of new Growth organization

•Awarded contract modification valued at approximately $24 million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

•Awarded 'Standing Offer' for NARCAN® Nasal Spray from the Government of Canada

•Announced commitment to cross-sector collaboration against biological threats in an evolving global security environment

•Announced ongoing commitment to opioid overdose education and preparedness on International Overdose Awareness Day

THIRD QUARTER 2026 FINANCIAL PERFORMANCE (1)

Revenues

The Company uses the following categories in discussing revenues:

•Naloxone — comprises contributions from NARCAN® Nasal Spray and KLOXXADO® Nasal Spray

•Anthrax MCM — comprises contributions from CYFENDUS®, BioThrax®, ANTHRASIL®, and Raxibacumab

•Smallpox MCM — comprises contributions from ACAM2000®, CNJ-016® (VIGIV) and TEMBEXA®

•Other Products — comprises contributions from BAT®

•All Other Revenues — comprises revenues from the Services operating segment and contracts and grants revenues

($ in millions)Q3 2026Q3 2025 $ Change % Change

Product sales, net: (3)

Naloxone $43.5 $74.9 $(31.4)(42)%

Anthrax MCM25.1 1.4 23.7 NM

Smallpox MCM26.7 83.6 (56.9)(68)%

Other Products7.6 57.5 (49.9)(87)%

Total Product sales, net$102.9 $217.4 $(114.5)(53)%

All other revenues7.1 13.7 (6.6)(48)%

Total revenues$110.0 $231.1 $(121.1)(52)%

NM - Not Meaningful

Product Sales, net (3)

Naloxone

For Q3 2026, revenues from Naloxone products decreased $31.4 million, or 42%, as compared with Q3 2025. The decrease was primarily attributable to lower sales of OTC NARCAN®, mostly driven by an unfavorable price-volume mix in U.S. public interest channels, partially mitigated by increases in Canadian sales of branded NARCAN®.

2

Anthrax MCM

For Q3 2026, revenues from Anthrax MCM products increased $23.7 million as compared with Q3 2025. The increase was primarily attributable to higher USG sales of CYFENDUS® due to timing. Anthrax vaccine produc

2026
Q2

Q2 2026 Earnings

8-K SELL

Aug 5, 2026 · 100% conf.

AI Prediction SELL

1D

-8.70%

$6.88

Act: -29.58%

5D

-14.38%

$6.46

20D

-19.66%

$6.06

Price: $7.54 Prob +5D: 0% AUC: 1.000
0001367644-26-000080

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1786368334.caccfd13

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

2026
Q1

Q1 2026 Earnings

8-K BUY

Apr 30, 2026 · 100% conf.

AI Prediction BUY

1D

+25.20%

$10.30

Act: +1.94%

5D

+25.45%

$10.32

Act: +10.94%

20D

+26.13%

$10.38

Act: +10.93%

Price: $8.23 Prob +5D: 100% AUC: 1.000
0001367644-26-000059

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.c706d217.1784585441.cf3197c

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

About Emergent Biosolutions Inc. (EBS) Earnings

This page provides Emergent Biosolutions Inc. (EBS) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.

Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on EBS's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.

Share on Social Networks: